Methods used in the diagnosis of hematological malignancies are constantly evolving, with novel technologies being developed, and an increased importance being placed on earlier diagnosis, patient risk stratification, and genomic testing. Discover the latest in the field in several disease areas, including multiple myeloma, CLL, AML, ALL, and lymphoma.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter